Challenges to environmental toxicology and epidemiology: where do we stand and which way do we go?


Autoria(s): Pesch, B; Bruning, T; Frentzel-Beyme, R; Johnen, G; Harth, V; Hoffmann, W; Ko, Y; Ranft, U; Traugott, UG; Thier, R; Taeger, D; Bolt, HM
Contribuinte(s)

J. Kehrer

W. Dekant

Data(s)

01/01/2004

Resumo

Modern toxicology investigates a wide array of both old and new health hazards. Priority setting is needed to select agents for research from the plethora of exposure circumstances. The changing societies and a growing fraction of the aged have to be taken into consideration. A precise exposure assessment is of importance for risk estimation and regulation. Toxicology contributes to the exploration of pathomechanisms to specify the exposure metrics for risk estimation. Combined effects of co-existing agents are not yet sufficiently understood. Animal experiments allow a separate administration of agents which can not be disentangled by epidemiological means, but their value is limited for low exposure levels in many of today's settings. As an experimental science, toxicology has to keep pace with the rapidly growing knowledge about the language of the genome and the changing paradigms in cancer development. During the pioneer era of assembling a working draft of the human genome, toxicogenomics has been developed. Gene and pathway complexity have to be considered when investigating gene-environment interactions. For a best conduct of studies, modem toxicology needs a close liaison with many other disciplines like epidemiology and bioinformatics. (C) 2004 Elsevier Ireland Ltd. All rights reserved.

Identificador

http://espace.library.uq.edu.au/view/UQ:74676

Idioma(s)

eng

Publicador

Elsevier

Palavras-Chave #Toxicology #Exposure Assessment #Gene-environment Interaction #Toxicogenomics #Pathomechanism #Complex Human-diseases #Lung-cancer Risk #Dna Methylation #Genetic Susceptibility #Industrial-chemicals #Human Genome #Association #Carcinogenicity #Polymorphisms #Chromatin #C1
Tipo

Journal Article